Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Busch

Showing results (331-340 of 504) with videos related to

Pageof 51
Sort By:
Transfusion|March 29, 2003
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infectionDavid M Asmuth, Leslie A Kalish, Megan E Laycock, et al.
Transfusion|August 14, 2012
Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virusCesar de Almeida-Neto, Ester Cerdeira Sabino, Jing Liu, et al.
Transfusion|June 21, 2022
Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reductionSusan L Stramer, Marion C Lanteri, Jaye P Brodsky, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population IncidenceSheila M Keating, Reshma Kassanjee, Mila Lebedeva, et al.
Microbiology Spectrum|June 22, 2023
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance ApplicationsHasan Sulaeman, Eduard Grebe, Honey Dave, et al.
Transfusion|February 8, 2021
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assayErin Goodhue Meyer, Graham Simmons, Eduard Grebe, et al.
Plos Pathogens|October 15, 2019
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individualsElizabeth R Wonderlich, Krupa Subramanian, Bryan Cox, et al.
Transfusion|May 10, 2008
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virusMichael K Hourfar, Christine Jork, Volkmar Schottstedt, et al.
The Journal of Infectious Diseases|March 16, 2011
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell responseHiroyu Hatano, Timothy L Hayes, Viktor Dahl, et al.
Transfusion|August 30, 2020
Recently acquired infection among HIV-seropositive donors in the US from 2010-2018Claire Quiner, Roberta Bruhn, Eduard Grebe, et al.
Pageof 51

Showing results (331-340 of 504) with videos related to

Sort By:
Pageof 51
Transfusion|March 29, 2003
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infectionDavid M Asmuth, Leslie A Kalish, Megan E Laycock, et al.
Transfusion|August 14, 2012
Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virusCesar de Almeida-Neto, Ester Cerdeira Sabino, Jing Liu, et al.
Transfusion|June 21, 2022
Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reductionSusan L Stramer, Marion C Lanteri, Jaye P Brodsky, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2016
Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population IncidenceSheila M Keating, Reshma Kassanjee, Mila Lebedeva, et al.
Microbiology Spectrum|June 22, 2023
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance ApplicationsHasan Sulaeman, Eduard Grebe, Honey Dave, et al.
Transfusion|February 8, 2021
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assayErin Goodhue Meyer, Graham Simmons, Eduard Grebe, et al.
Plos Pathogens|October 15, 2019
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individualsElizabeth R Wonderlich, Krupa Subramanian, Bryan Cox, et al.
Transfusion|May 10, 2008
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virusMichael K Hourfar, Christine Jork, Volkmar Schottstedt, et al.
The Journal of Infectious Diseases|March 16, 2011
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell responseHiroyu Hatano, Timothy L Hayes, Viktor Dahl, et al.
Transfusion|August 30, 2020
Recently acquired infection among HIV-seropositive donors in the US from 2010-2018Claire Quiner, Roberta Bruhn, Eduard Grebe, et al.
Pageof 51